Table 3.
Comparison of the potency of glyceryl trinitrate (–log EC50) against U46619-induced contractions following exposure to 30 µM glyceryl trinitrate (GTN) with or without quercetin or quercetin metabolites (n= 8)
| Control | 30 µM GTN 90 min | 30 µM GTN 90 min 10 µM Quercetin |
| 7.13 ± 0.09 | 5.58 ± 0.07 | 6.59 ± 0.22* |
| Control | 30 µM GTN 90 min | 30 µM GTN 90 min 10 µM Quercetin glucuronide |
| 6.81 ± 0.13 | 6.09 ± 0.09 | 6.13 ± 0.12 |
| Control | 30 µM GTN 90 min | 30 µM GTN 90 min 10 µM Quercetin sulphate |
| 6.83 ± 11 | 5.92 ± 0.15 | 6.57 ± 0.15* |
Significant difference (P < 0.05, paired Student's t-test) in potency compared to tissue exposed to 30 µM glyceryl trinitrate alone.